Picard Medical, Inc. (PMI) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon. Welcome to Picard Medical's first annual business update, featuring key opinion leaders and a patient testimonial. Before we begin, I'd like to remind you that management will be making projections and forward-looking statements on the call today regarding future events. Any statements that are not historical facts are forward-looking statements. These statements are made pursuant to and within the meaning of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. We encourage you to review Picard Medical's SEC filings, which identify risks and uncertainties that may cause future actual results or events to differ materially. These filings can be found on the company's website within the investor relations section, as well as the SEC's website at www.sec.gov. Please note that the forward-looking statements made during today's call speak only to the date they were made, and Picard Medical undertakes no obligation to update them. Also, please see this slide with additional disclaimers related to the content within today's talk. And note that a question and answer session will follow the formal presentations. If you'd like to submit a question, you may do so by using the Q&A text box at the bottom of this webcast player or by emailing your questions to questions at LifeSiteAdvisors.com. As a reminder, this call is being recorded and a replay will be made available on the Picard website following the conclusion of the event. And with that, I'd like to now turn the call over to Patrick Schneckelsberg, Chief Executive Officer of Picard Medical. Patrick. Thank you, Dori. Really appreciate the intro. If we can go to the next slide. Thank you. At Picard Medical, our mission is to pioneer the future of heart replacement. We are pursui...